'We are ready to go': FDA OKs J&J and Legend's BCMA CAR-T, setting stage for showdown with Bristol Myers - Endpoints News
2/28/2022 12:00:00 AM3 years 2 months ago
by Nicole DeFeudis
by Nicole DeFeudis
Move over, Bristol Myers Squibb. After delaying their decision by three months to review new information, the FDA has cleared Johnson & Johnson and Legend’s BCMA CAR-T rival cilta-cel, setting the stage for a showdown in multiple myeloma. Cilta-cel — which wi…
Move over, Bristol Myers Squibb. After delaying their decision by three months to review new information, the FDA has cleared Johnson & Johnson and Legends BCMA CAR-T rival cilta-cel, setting the… [+5129 chars]
full article...